A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double--Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels ≥500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment
Каталог · ЕАЭС
Клинические исследования и проекты
Kowa Research Institute, Inc. · найдено 3
3 исследования
Завершено
Фаза III
Беларусь
K-877 · Kowa Research Institute, Inc.
Завершено
Фаза III
Беларусь
K-877 · Kowa Research Institute, Inc.
A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With a 40-Week, Active-Controlled, Double-Blind Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels ≥500 mg/dL and <2000 mg/dL and Normal Renal Function
Завершено
Фаза II
Россия
K-134; Cilostazol 100 mg BID; Placebo · Kowa Research Institute, Inc.
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication